Key facts
- This page summarizes PALMISANO ROBERT J's Form 4/A - Amendment filing for AEON Biopharma, Inc. (AEON).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 10 Sep 2024, 21:04.
PALMISANO ROBERT J - 31 Aug 2024 Form 4/A - Amendment Insider Report for AEON Biopharma, Inc. (AEON)
- Reporting relationship
- Director
- Issuer ticker
- AEON
- Reported as of
- 31 Aug 2024
- Net transaction value
- $0
- SEC form
- 4/A - Amendment
- Accepted by SEC
- 10 Sep 2024, 21:04:24 UTC
- Original report date
- 04 Sep 2024
- Prior SEC filing
- 10 Jun 2024
- Next SEC filing
- 23 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Alexander Wilson as attorney-in-fact for Robert J. Palmisano
Source evidence
Original filing metadata and source links for verification.
6 source fields
Reporting owner
1 detail
Key filing fact
PALMISANO ROBERT J filed Form 4/A - Amendment for AEON Biopharma, Inc. (AEON) on 10 Sep 2024.
Change
- Previous filing in this sequence was filed on 10 Jun 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AEON
transaction
Class A Common Stock
Award
- Transaction value
- $0
- Shares
- +36,021
- Change %
- Price
- $0.000000
- Shares after
- 36,021
- Date
- 31 Aug 2024
- Ownership
- Direct
- Footnotes
- F1
AEON
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,265,000
- Date
- 31 Aug 2024
- Ownership
- By Family LLC
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents an award of restricted stock units granted on August 31, 2024 (the "Grant Date"), which vests in full on the second anniversary of the Grant Date, subject to the reporting person's continued service through the applicable vesting date.
Footnote F2
Represents shares of Class A Common Stock which are held by The Palmisano Family, LLC pursuant to recent pro rata distributions on July 19, 2024 as to 1,115,000 shares and on July 25, 2024 as to 1,150,000 shares, and which were inadvertently omitted from the reporting person's Form 4 filed on 9/4/2024.